XSHG
603299
Market cap1.24bUSD
Oct 09, Last price
8.77CNY
1D
0.69%
1Q
-3.41%
Jan 2017
-49.63%
IPO
50.17%
Name
JiangSu Suyan Jingshen Co Ltd
Chart & performance
P/E
15.97
P/S
1.85
EPS
0.55
Div yield, %
5.09%
Shrs. gr., 5y
0.19%
Rev. gr., 5y
2.74%
Revenues
4.51b
-15.68%
Net income
522m
-32.11%
CFO
360m
-71.94%
Dividend
Jun 18, 20260.252 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jiang Su Suyan Jingshen Co.,Ltd. is dedicated to the research, manufacturing, distribution, and sale of salt and a variety of salt-based chemical products throughout Southeast Asia. The company's comprehensive product offerings include both industrial and edible salts, as well as specialized chemicals such as calcined soda, sodium sulfate, and calcium chloride. These are sold under its established brands: Huaiyan, Yinfei, Yunyun, Jingshen, and Sizhou. Founded in 2009, the firm's main office is located in Huai'an, China. It adopted its current name, Jiang Su Suyan Jingshen Co.,Ltd., in January 2019, having previously operated as Jiangsu Jingshen Salt & Chemical Industry Co., Ltd. The company functions as a subsidiary of Jiangsu Salt Industry Group Co.,Ltd.
Key people
Lisong Xiao
Vice Chairman of the Board · since 2024
Haijun Xu
Finance Director, Chief Accounting Officer · since 2024
Liang Dai
General Counsel, Secretary of the Board · since 2024
Guangxu Ding
Executive Deputy General Manager, Director · since 2024
Xudong Zhang
Deputy General Manager · since 2021
Minqian Zhao
Deputy General Manager · since 2024
Qingwang Shang
Assistant to General Manager · since 2024
Qiming Dai
Director · since 2024
Zexiang Wan
Staff Elected Director · since 2025
Haiqing Wang
Director · since 2022
Xufeng Wu
Chairman of the Board · since 2018
Independent Director · since 2022
Yonghong Hu
Independent Director · since 2025
Independent Director · since 2022
Headquarters & legal address
江苏省淮安市淮安区华西路18号
淮安市, JS 100000
CN
淮安市, JS 100000
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||